• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tmprss2 特异性 microRNA 作为 SARS-CoV-2 进入检查点的有希望的调节剂。

Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint.

机构信息

Animal Biochemistry Division, ICAR-National Dairy Research Institute, Karnal, Haryana, 132001, India.

Animal Biochemistry Division, ICAR-National Dairy Research Institute, Karnal, Haryana, 132001, India.

出版信息

Virus Res. 2021 Mar;294:198275. doi: 10.1016/j.virusres.2020.198275. Epub 2021 Jan 8.

DOI:10.1016/j.virusres.2020.198275
PMID:33359190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7833564/
Abstract

Tmprss2 is an emerging molecular target which guides cellular infections of SARS-CoV-2, has been earmarked for interventions against the viral pathologies. The study aims to computationally screen and identifies potential miRNAs, following in vitro experimental validation of miRNA-mediated suppression of Tmprss2 for early prevention of COVID-19. Pool of 163 miRNAs, scrutinized for Tmprss2 binding with three miRNA prediction algorithms, ensued 11 common miRNAs. Further, computational negative energies for association, corroborated miRNA-Tmprss2 interactions, whereas three miRNAs (hsa-miR-214, hsa-miR-98 and hsa-miR-32) based on probability scores ≥0.8 and accessibility to Tmprss2 target have been selected in the Sfold tool. Transfection of miRNA(s) in the Caco-2 cells, quantitatively estimated differential expression, confirming silencing of Tmprss2 with maximum gene suppression by hsa-miR-32 employing novel promising role in CoV-2 pathogenesis. The exalted binding of miRNAs to Tmprss2 and suppression of later advocates their utility as molecular tools for prevention of SARS-CoV-2 viral transmission and replication in humans.

摘要

Tmprss2 是一种新兴的分子靶点,指导 SARS-CoV-2 的细胞感染,已被指定用于干预病毒病理学。本研究旨在通过体外实验验证 miRNA 介导的 Tmprss2 抑制作用,以进行 COVID-19 的早期预防,从而进行计算筛选和鉴定潜在的 miRNA。对 163 种 miRNA 进行了筛选,用三种 miRNA 预测算法对 Tmprss2 进行了分析,得到了 11 种常见的 miRNA。进一步,计算出的结合能证实了 miRNA-Tmprss2 的相互作用,而基于概率评分≥0.8 和对 Tmprss2 靶标可达性的三种 miRNA(hsa-miR-214、hsa-miR-98 和 hsa-miR-32)已被选中在 Sfold 工具中进行研究。在 Caco-2 细胞中转染 miRNA(s),定量估计差异表达,证实了 hsa-miR-32 对 Tmprss2 的沉默作用,这表明其在 CoV-2 发病机制中具有新的潜在作用。miRNA 与 Tmprss2 的高度结合以及对后者的抑制作用表明,它们可用作预防 SARS-CoV-2 病毒在人类中传播和复制的分子工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/c2b217cfd217/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/bd934ed80001/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/651a228a4e57/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/c91902b7f266/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/106921017c04/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/82e5db75383c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/ec111a8a7438/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/cc7cdf22285c/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/c2b217cfd217/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/bd934ed80001/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/651a228a4e57/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/c91902b7f266/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/106921017c04/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/82e5db75383c/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/ec111a8a7438/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/cc7cdf22285c/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08d6/7833564/c2b217cfd217/gr7_lrg.jpg

相似文献

1
Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint.Tmprss2 特异性 microRNA 作为 SARS-CoV-2 进入检查点的有希望的调节剂。
Virus Res. 2021 Mar;294:198275. doi: 10.1016/j.virusres.2020.198275. Epub 2021 Jan 8.
2
Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.宿主 microRNAs 对 SARS-CoV-2、病毒进入蛋白 ACE2 和 TMPRSS2 及干扰素基因的靶向计算分析。
Genes (Basel). 2020 Nov 16;11(11):1354. doi: 10.3390/genes11111354.
3
In Silico Identification of miRNA-lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection.基于计算机的 COVID-19 感染相关男性生殖障碍中 miRNA-lncRNA 相互作用的鉴定。
Cells. 2021 Jun 12;10(6):1480. doi: 10.3390/cells10061480.
4
Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.SARS-CoV-2 感染仓鼠肺组织中 microRNAs 的表达分析。
Mol Cells. 2020 Nov 30;43(11):953-963. doi: 10.14348/molcells.2020.0177.
5
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.microRNAs 在调节人类细胞中 SARS-CoV-2 感染中的作用:系统评价。
Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1.
6
TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells.TMPRSS2 表达决定了 SARS-CoV-2 感染宿主细胞所使用的进入途径。
EMBO J. 2021 Aug 16;40(16):e107821. doi: 10.15252/embj.2021107821. Epub 2021 Jul 13.
7
SARS-COV-2 as potential microRNA sponge in COVID-19 patients.SARS-CoV-2 作为 COVID-19 患者中的潜在 miRNA 海绵。
BMC Med Genomics. 2022 Apr 23;15(Suppl 2):94. doi: 10.1186/s12920-022-01243-7.
8
Host microRNAs exhibit differential propensity to interact with SARS-CoV-2 and variants of concern.宿主 microRNAs 表现出与 SARS-CoV-2 和关注变异株不同的相互作用倾向。
Biochim Biophys Acta Mol Basis Dis. 2023 Feb;1869(2):166612. doi: 10.1016/j.bbadis.2022.166612. Epub 2022 Dec 5.
9
Differential microRNA expression in the peripheral blood from human patients with COVID-19.COVID-19 患者外周血中的差异 microRNA 表达。
J Clin Lab Anal. 2020 Oct;34(10):e23590. doi: 10.1002/jcla.23590. Epub 2020 Sep 22.
10
Cellular microRNAs target SARS-CoV-2 spike protein and restrict viral replication.细胞 microRNAs 靶向 SARS-CoV-2 刺突蛋白并限制病毒复制。
Am J Physiol Cell Physiol. 2023 Aug 1;325(2):C420-C428. doi: 10.1152/ajpcell.00516.2022. Epub 2023 Jul 3.

引用本文的文献

1
A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection.关于微小RNA与病毒发病机制及感染之间相互作用的全面综述。
Med Res Rev. 2025 Mar;45(2):349-425. doi: 10.1002/med.22073. Epub 2024 Aug 26.
2
Evaluation of the Relationship Between Serum miR-200b-3p and miR-214-3p Expression Levels with Soluble ACE2 and TMPRSS2 in COVID-19 Patients.COVID-19患者血清miR-200b-3p和miR-214-3p表达水平与可溶性血管紧张素转换酶2(sACE2)和跨膜丝氨酸蛋白酶2(TMPRSS2)之间关系的评估
Iran J Pharm Res. 2023 Oct 11;22(1):e137832. doi: 10.5812/ijpr-137832. eCollection 2023 Jan-Dec.
3
Environmental dissemination of respiratory viruses: dynamic interdependencies of respiratory droplets, aerosols, aerial particulates, environmental surfaces, and contribution of viral re-aerosolization.

本文引用的文献

1
microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines.病毒急性呼吸道感染中的微小RNA:免疫调节、生物标志物、治疗及疫苗
ExRNA. 2019;1(1):1. doi: 10.1186/s41544-018-0004-7. Epub 2019 Feb 14.
2
Cell derived extracellular matrix-rich biomimetic substrate supports podocyte proliferation, differentiation and maintenance of native phenotype.细胞衍生的富含细胞外基质的仿生底物支持足细胞增殖、分化并维持其天然表型。
Adv Funct Mater. 2020 Oct 28;30(44). doi: 10.1002/adfm.201908752. Epub 2020 Feb 19.
3
Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies.
呼吸道病毒的环境传播:呼吸道飞沫、气溶胶、空气颗粒、环境表面的动态相互依存关系,以及病毒再气溶胶化的作用。
PeerJ. 2023 Nov 24;11:e16420. doi: 10.7717/peerj.16420. eCollection 2023.
4
Identification of Hub Genes and Typing of Tuberculosis Infections Based on Autophagy-Related Genes.基于自噬相关基因鉴定结核分枝杆菌感染的枢纽基因和分型。
Pol J Microbiol. 2023 Sep 20;72(3):223-238. doi: 10.33073/pjm-2023-022. eCollection 2023 Sep 1.
5
The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中长链非编码RNA(lncRNAs)和微小RNA(miRNAs)的调控
Front Cell Dev Biol. 2023 Jul 27;11:1229393. doi: 10.3389/fcell.2023.1229393. eCollection 2023.
6
Evaluation of altered miRNA expression pattern to predict COVID-19 severity.评估改变的微小RNA表达模式以预测新冠病毒疾病的严重程度。
Heliyon. 2023 Feb;9(2):e13388. doi: 10.1016/j.heliyon.2023.e13388. Epub 2023 Feb 1.
7
analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs.分析 SARS-CoV-2 基因组:来自 SARS 编码非编码 RNA 的启示。
Front Cell Infect Microbiol. 2022 Nov 28;12:966870. doi: 10.3389/fcimb.2022.966870. eCollection 2022.
8
miRNAs: The Key Regulator of COVID-19 Disease.微小RNA:新冠病毒疾病的关键调节因子
Int J Cell Biol. 2022 Oct 29;2022:1645366. doi: 10.1155/2022/1645366. eCollection 2022.
9
Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells.肠道微生物群及其代谢产物对 Caco-2 细胞介导 SARS-CoV-2 发病机制的 ACE、AGTR1 和 ACE2 基因的下调作用。
Microb Pathog. 2022 Dec;173(Pt A):105798. doi: 10.1016/j.micpath.2022.105798. Epub 2022 Sep 26.
10
SARS-CoV-2 infection and replication kinetics in different human cell types: The role of autophagy, cellular metabolism and ACE2 expression.SARS-CoV-2 感染和复制动力学在不同的人类细胞类型中:自噬、细胞代谢和 ACE2 表达的作用。
Life Sci. 2022 Nov 1;308:120930. doi: 10.1016/j.lfs.2022.120930. Epub 2022 Sep 6.
对来自不同地理位置的新型冠状病毒基因组进行综合分析,揭示了可能对宿主与病毒相互作用、发病机制以及新疗法线索具有重要意义的独特特征。
Heliyon. 2020 Sep;6(9):e04658. doi: 10.1016/j.heliyon.2020.e04658. Epub 2020 Aug 20.
4
miR300 intervenes Smad3/β-catenin/RunX2 crosstalk for therapy with an alternate function as indicative biomarker in osteoporosis.miR300 通过发挥指示性生物标志物的作用干预 Smad3/β-catenin/RunX2 串话,为骨质疏松症的治疗提供了一种替代功能。
Bone. 2021 Feb;143:115603. doi: 10.1016/j.bone.2020.115603. Epub 2020 Aug 20.
5
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.静脉注射N-乙酰半胱氨酸对重症新型冠状病毒肺炎感染进行炎症的治疗性阻断。
Clin Immunol. 2020 Oct;219:108544. doi: 10.1016/j.clim.2020.108544. Epub 2020 Jul 22.
6
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.TMPRSS2 和 furin 均是 SARS-CoV-2 在人呼吸道细胞中蛋白水解激活所必需的。
Life Sci Alliance. 2020 Jul 23;3(9). doi: 10.26508/lsa.202000786. Print 2020 Sep.
7
Imatinib for COVID-19: A case report.伊马替尼治疗新型冠状病毒肺炎:一例病例报告。
Clin Immunol. 2020 Sep;218:108518. doi: 10.1016/j.clim.2020.108518. Epub 2020 Jun 27.
8
Treating COVID-19 with colchicine in community healthcare setting.在社区医疗环境中使用秋水仙碱治疗新冠病毒病
Clin Immunol. 2020 Aug;217:108490. doi: 10.1016/j.clim.2020.108490. Epub 2020 May 31.
9
TMPRSS2: Potential Biomarker for COVID-19 Outcomes.跨膜丝氨酸蛋白酶2:新冠病毒疾病结局的潜在生物标志物
J Clin Pharmacol. 2020 Jul;60(7):801-807. doi: 10.1002/jcph.1641. Epub 2020 May 21.
10
Camostat mesilate therapy for COVID-19.甲磺酸卡莫司他治疗新型冠状病毒肺炎
Intern Emerg Med. 2020 Nov;15(8):1577-1578. doi: 10.1007/s11739-020-02345-9. Epub 2020 Apr 29.